share_log

阿里健康:重續不獲豁免持續關連交易 及 股東特別大會通告

ALI HEALTH: RENEWAL OF NON-EXEMPT CONTINUING CONNECTED TRANSACTIONS AND NOTICE OF SPECIAL GENERAL MEETING

香港交易所 ·  Mar 6 08:45
Summary by Moomoo AI
阿里健康信息技術有限公司(「阿里健康」)將於2024年3月26日舉行股東特別大會,審議與杭州阿里媽媽軟件服務有限公司及淘寶中國控股有限公司訂立的2025年至2027年營銷推廣服務框架協議及框架技術服務協議。該等協議將延續現有的營銷推廣及軟件技術服務安排,並設定了截至2027年3月31日止三個年度的建議年度上限。獨立董事委員會及獨立財務顧問均已就此事宜向獨立股東提供意見及推薦建議,認為交易條款公平合理,並符合公司及股東整體利益。股東特別大會將就上述協議及交易進行表決。
阿里健康信息技術有限公司(「阿里健康」)將於2024年3月26日舉行股東特別大會,審議與杭州阿里媽媽軟件服務有限公司及淘寶中國控股有限公司訂立的2025年至2027年營銷推廣服務框架協議及框架技術服務協議。該等協議將延續現有的營銷推廣及軟件技術服務安排,並設定了截至2027年3月31日止三個年度的建議年度上限。獨立董事委員會及獨立財務顧問均已就此事宜向獨立股東提供意見及推薦建議,認為交易條款公平合理,並符合公司及股東整體利益。股東特別大會將就上述協議及交易進行表決。
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. (“ALI HEALTH”) WILL HOLD A SPECIAL GENERAL MEETING ON MARCH 26, 2024 TO REVIEW THE 2025 TO 2027 MARKETING PROMOTION SERVICES FRAMEWORK AGREEMENT AND FRAMEWORK TECHNOLOGY SERVICES AGREEMENT WITH HANGZHOU ALIMA SOFTWARE SERVICES LIMITED AND TAOBAO CHINA HOLDINGS LIMITED. The agreements will continue existing marketing promotion and software technical services arrangements and set a maximum recommended year for the three years ended March 31, 2027. The Independent Board of Directors and the Independent Financial Adviser have provided advice and recommendations to the Independent Shareholders on this matter in the opinion that the terms of the transaction are fair and reasonable and in the overall interests of the Company and its shareholders. The Extraordinary General Meeting will vote on the above Agreement and Transaction.
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. (“ALI HEALTH”) WILL HOLD A SPECIAL GENERAL MEETING ON MARCH 26, 2024 TO REVIEW THE 2025 TO 2027 MARKETING PROMOTION SERVICES FRAMEWORK AGREEMENT AND FRAMEWORK TECHNOLOGY SERVICES AGREEMENT WITH HANGZHOU ALIMA SOFTWARE SERVICES LIMITED AND TAOBAO CHINA HOLDINGS LIMITED. The agreements will continue existing marketing promotion and software technical services arrangements and set a maximum recommended year for the three years ended March 31, 2027. The Independent Board of Directors and the Independent Financial Adviser have provided advice and recommendations to the Independent Shareholders on this matter in the opinion that the terms of the transaction are fair and reasonable and in the overall interests of the Company and its shareholders. The Extraordinary General Meeting will vote on the above Agreement and Transaction.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more